ANALYSIS: Investors have lost millions and companies have collapsed, but medicinal cannabis players still see a bright future.
ANALYSIS: The numbers tell a story of resilience, generally strong provisions and capital, and low loan impairments.
ANALYSIS: The new public research organisation will invest in research but do no research itself.
Apart from navigating US President Trumps tariff announcements, also on Braid’s Mainfreight plate in 2025 is the vexed question of what will be done about the Cook Strait ferry debacle.
ANALYSIS: Why doing something always beats doing nothing.
An unauthorised biography looks back and forward on a controversial prime minister.
ANALYSIS: Required is leadership from universities, commitment from senior academics, and a collective willingness to re-imagine how research careers are built.
ANALYSIS: Winston Peters and Christopher Luxon disagree over asset sales.
ANALYSIS: Shareholders may well discover a bee in the hand is worth two in the bush.
ANALYSIS: Burdened by a costly external management contract for years, the property fund grabs a $214m exit.